Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc (SNDX) Insider Trading
Directors, officers and holders of more than 10% of SNDX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 79 transactions on file: 0 with code P, 15 with code S and 35 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | Podlesak Dennis | Director | M Exercise | 8,000 | $11.81 | $94,480 |
| Oct 29, 2026 | Podlesak Dennis | Director | M Exercise | 8,000 | Not measured | Not measured |
| Oct 29, 2026 | Podlesak Dennis | Director | S Sale | 8,000 | $14.21 | $113,716 |
| Jul 8, 2026 | Metzger Michael A | Chief Executive Officer | M Exercise | 32,375 | $6.38 | $206,553 |
| Jul 8, 2026 | Metzger Michael A | Chief Executive Officer | M Exercise | 32,375 | Not measured | Not measured |
| Jul 8, 2026 | Metzger Michael A | Chief Executive Officer | S Sale | 32,375 | $24.24 | $784,776 |
| Jun 12, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | S Sale | 31,235 | $18.14 | $566,603 |
| Jun 12, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | M Exercise | 31,235 | Not measured | Not measured |
| Jun 12, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | M Exercise | 31,235 | $13.82 | $431,668 |
| Jun 11, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | M Exercise | 22,515 | Not measured | Not measured |
| Jun 11, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | S Sale | 34,280 | $18.00 | $617,040 |
| Jun 11, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | M Exercise | 22,515 | $13.82 | $311,157 |
| Jun 1, 2026 | Goldan Keith A. | Chief Financial Officer | S Sale | 1,177 | $18.99 | $22,351 |
| Jun 1, 2026 | Metzger Michael A | Chief Executive Officer | S Sale | 6,847 | $18.99 | $130,025 |
| Feb 9, 2026 | Goldan Keith A. | Chief Financial Officer | S Sale | 3,410 | $21.03 | $71,705 |
| Feb 9, 2026 | Metzger Michael A | Chief Executive Officer | S Sale | 17,159 | $21.03 | $360,819 |
| Feb 6, 2026 | Goldan Keith A. | Chief Financial Officer | S Sale | 2,082 | $20.62 | $42,931 |
| Feb 6, 2026 | Metzger Michael A | Chief Executive Officer | S Sale | 7,412 | $20.62 | $152,835 |
| Feb 4, 2026 | Rizo Aleksandra | Director | A Award | 24,000 | Not measured | Not measured |
| Feb 4, 2026 | Katkin Keith | Director | A Award | 24,000 | Not measured | Not measured |
| Feb 4, 2026 | Podlesak Dennis | Director | A Award | 48,000 | Not measured | Not measured |
| Feb 4, 2026 | Legault Pierre | Director | A Award | 24,000 | Not measured | Not measured |
| Feb 4, 2026 | Metzger Michael A | Chief Executive Officer | A Award | 440,000 | $20.43 | $8,989,200 |
| Feb 4, 2026 | Goldan Keith A. | Chief Financial Officer | A Award | 118,000 | $20.43 | $2,410,740 |
| Feb 4, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | A Award | 144,700 | $20.43 | $2,956,221 |
| Feb 4, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | A Award | 36,000 | Not measured | Not measured |
| Feb 4, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | A Award | 24,000 | Not measured | Not measured |
| Feb 4, 2026 | Goldan Keith A. | Chief Financial Officer | A Award | 30,750 | Not measured | Not measured |
| Feb 4, 2026 | Goldan Keith A. | Chief Financial Officer | A Award | 21,500 | Not measured | Not measured |
| Feb 4, 2026 | Metzger Michael A | Chief Executive Officer | A Award | 73,000 | Not measured | Not measured |
| Feb 4, 2026 | Jarrett Jennifer | Director | A Award | 24,000 | Not measured | Not measured |
| Feb 4, 2026 | Huber Martin H. Jr. | Director | A Award | 24,000 | Not measured | Not measured |
| Feb 4, 2026 | Metzger Michael A | Chief Executive Officer | A Award | 144,600 | Not measured | Not measured |
| Jan 30, 2026 | Goldan Keith A. | Chief Financial Officer | J Other | 1,219 | $8.48 | $10,337 |
| Dec 1, 2025 | Goldan Keith A. | Chief Financial Officer | G Gift | 1,224 | Not measured | Not measured |
| Sep 8, 2025 | Metzger Michael A | Chief Executive Officer | M Exercise | 157,307 | $10.90 | $1,714,646 |
| Sep 8, 2025 | Metzger Michael A | Chief Executive Officer | M Exercise | 157,307 | Not measured | Not measured |
| Sep 8, 2025 | Metzger Michael A | Chief Executive Officer | S Sale | 157,307 | $16.41 | $2,582,021 |
| Aug 18, 2025 | Podlesak Dennis | Director | M Exercise | 19,200 | $7.20 | $138,240 |
| Aug 18, 2025 | Podlesak Dennis | Director | M Exercise | 19,200 | Not measured | Not measured |
| Aug 18, 2025 | Podlesak Dennis | Director | S Sale | 19,200 | $15.84 | $304,170 |
| Aug 15, 2025 | Podlesak Dennis | Director | M Exercise | 4,800 | Not measured | Not measured |
| Aug 15, 2025 | Podlesak Dennis | Director | M Exercise | 14,400 | Not measured | Not measured |
| Aug 15, 2025 | Podlesak Dennis | Director | M Exercise | 19,200 | $7.20 | $138,240 |
| Aug 15, 2025 | Podlesak Dennis | Director | S Sale | 19,200 | $15.54 | $298,408 |
| Aug 14, 2025 | Podlesak Dennis | Director | S Sale | 19,200 | $14.19 | $272,521 |
| Aug 14, 2025 | Podlesak Dennis | Director | M Exercise | 19,200 | Not measured | Not measured |
| Aug 14, 2025 | Podlesak Dennis | Director | M Exercise | 19,200 | $7.20 | $138,240 |
| Jul 31, 2025 | Goldan Keith A. | Chief Financial Officer | J Other | 1,226 | $8.43 | $10,335 |
| Jul 16, 2025 | Metzger Michael A | Chief Executive Officer | S Sale | 7,534 | $9.29 | $69,953 |
The full Form 4 history is on the SNDX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.